Cardiometabolic Disease / Obesity
Indication
Obesity
Assets addressing this indication.
Total attributable cost
$199.1B
$1,861/patient
Drug spend
$10.6B
$99/patient
5% of total cost is drugs
BMI >=30 (or >=27 with a weight-related comorbidity) · US
Cardiometabolic Disease / Obesity
Indication
Assets addressing this indication.
Total attributable cost
$199.1B
$1,861/patient
Drug spend
$10.6B
$99/patient
5% of total cost is drugs
BMI >=30 (or >=27 with a weight-related comorbidity) · US
120 of 120 assets